Taisho Pharmaceutical Holdings Stock Revenue
| TAIPYDelisted Stock | USD 14.00 0.00 0.00% |
Taisho Pharmaceutical Holdings fundamentals help investors to digest information that contributes to Taisho Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Taisho Pink Sheet. The fundamental analysis module provides a way to measure Taisho Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Taisho Pharmaceutical pink sheet.
Taisho |
Taisho Pharmaceutical Holdings Company Revenue Analysis
Taisho Pharmaceutical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Taisho Pharmaceutical Revenue | 268.2 B |
Most of Taisho Pharmaceutical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Taisho Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Taisho Pharmaceutical Holdings reported 268.2 B of revenue. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is significantly lower than that of the firm.
Taisho Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Taisho Pharmaceutical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Taisho Pharmaceutical could also be used in its relative valuation, which is a method of valuing Taisho Pharmaceutical by comparing valuation metrics of similar companies.Taisho Pharmaceutical is currently under evaluation in revenue category among its peers.
Taisho Fundamentals
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 327.94 M | |||
| Price To Earning | 20.67 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 268.2 B | |||
| Gross Profit | 163.83 B | |||
| EBITDA | 42.81 B | |||
| Net Income | 13.12 B | |||
| Cash And Equivalents | 276.54 B | |||
| Cash Per Share | 843.28 X | |||
| Current Ratio | 6.21 X | |||
| Book Value Per Share | 2,413 X | |||
| Cash Flow From Operations | 28.51 B | |||
| Earnings Per Share | 0.49 X | |||
| Number Of Employees | 9.13 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 3.35 B | |||
| Total Asset | 888.16 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 888.16 B | |||
| Last Dividend Paid | 50.0 |
About Taisho Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Taisho Pharmaceutical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taisho Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taisho Pharmaceutical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |